Rchr
J-GLOBAL ID:201801016620312454   Update date: Oct. 01, 2022

tomoya fukawa

tomoya fukawa
Affiliation and department:
Papers (40):
  • Kusuhara Y, Daizumoto K, Kawai K, Hirayama K, Kowada M, Shintani T, Fukuhara Y, Dondoo TO, Ozaki K, Tsuda M, et al. Low Expression of Toll-like Receptor 4 Is Associated With Poor Prognosis in Bladder Cancer. Anticancer research. 2019. 39. 2. 703-711
  • Kei Daizumoto, Tetsuro Yoshimaru, Yosuke Matsushita, Tomoya Fukawa, Hisanori Uehara, Masaya Ono, Masato Komatsu, Hiro-Omi Kanayama, Toyomasa Katagiri. A DDX31/Mutant-p53/EGFR Axis Promotes Multistep Progression of Muscle-Invasive Bladder Cancer. Cancer research. 2018. 78. 9. 2233-2247
  • Shimochi S, Daizumoto K, Ozaki K, Kusuhara Y, Fukawa T, Fukumori T, Takahashi M, Kanayama H. [Renal Angiomyolipoma Extending into the Renal Vein --A Case Report-]. Hinyokika kiyo. Acta urologica Japonica. 2018. 64. 5. 213-217
  • Daizumoto Kei, Fukuhara Yayoi, Ozaki Keisuke, Kusuhara Yoshito, Mori Hidehisa, Fukawa Tomoya, Yamamoto Yasuyo, Yamaguchi Kunihisa, Fukumori Tomoharu, Takahashi Masayuki, et al. GALECTIN-3 PLAYS CRITICAL ROLES FOR THE GROWTH OF BENIGN PROSTATIC HYPERPLASIA. JOURNAL OF UROLOGY. 2018. 199. 4. E604
  • Takahashi Masayuki, Daizumoto Kei, Fukuhara Yayoi, Ozaki Keisuke, Tsuda Megumi, Kusuhara Yoshito, Mori Hidehisa, Fukawa Tomoya, Yamamoto Yasuyo, Yamaguchi Kunihisa, et al. CORRELATION OF THE INSULIN RECEPTOR EXPRESSION AND THE RESISTANCE TO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS IN ADVANCED CLEAR CELL RENAL CELL CARCINOMA. JOURNAL OF UROLOGY. 2018. 199. 4. E954
more...
MISC (398):
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page